Português | English

ISSN (Print): 2359-4802 | ISSN (Online): 2359-5647

Article's Author

2 result(s) for: Esmeralci Ferreira

Bioresorbable device implantation in left main in patients with limitation for long-term using of dual antiplatelet therapy

Angioplastia no tronco calcificado com suporte biorreabsorvível por limitação para antiagregação

Esmeralci Ferreira; Alcides Ferreira Júnior; Cyro Vargues Rodirgues; Camillo de Lellis Carneiro Junqueira; Guilherme Nossar Matheus da Rocha; Leandro de Souza Duarte

Int J Cardiovasc Sci.2015;28(5):433-436 : Case Report

Abstract PDF PORT PDF ENGLISH

Male patient with unstable angina and critical calcified lesion in the left main coronary artery (LMCA). Background: coronary artery bypass grafting and anemia. The intention to treat was angioplasty with drug-eluting stents (DES) in the LMCA. The patient presented gastrointestinal bleeding and worsening of anemia, which were treated. Angina was refractory to medical therapy. Because of antiplatelet therapy limitation, bioresorbable vascular support (BVS) was implanted in the LMCA. This case report discusses the use of BVS in complex lesion, enabling absorption of the device and better management of antiplatelet therapy and future follow-up of the obstruction treated using by non-invasive imaging methods.


Percutaneous coronary intervention with bioresorbable vascular scaffolds

Intervenção coronariana percutânea com suportes vasculares biorreabsorvíveis

Márcio Macri Dias; Márcio José Montenegro da Costa; Bernardo Amorim; Esmeralci Ferreira

Int J Cardiovasc Sci.2016;29(4):314-319 : Review Article

Abstract PDF PORT PDF ENGLISH

Percutaneous coronary intervention (PCI) was the first revolution in interventional cardiology. Coronary stents solved the acute occlusion of the vessel, sealing dissections and preventing negative remodeling. Excessive intimal hyperplasia was reduced with drug-eluting stents (DES) mainly in diabetics, small vessels and long lesions. However, the mechanical effect of stent metal hinders the positive remodeling of the vessel wall, good endothelial function and vascular reactivity. Bioresorbable vascular scaffolds (BVS) provide good initial stability in the vascular structure and complete resorption of the material over time, resulting in better physiological adaptation of the artery. Recent studies show that these devices are safe. Despite some limitations in indication, evidence now offer unique options in the treatment of coronary artery disease (CAD) with the expansion of BVS use in daily practice, which is the reason for this review.


GN1